Makes revisions relating to Medicaid. (BDR 38-110)
Summary
SB300 revises Nevada Medicaid law to expand coverage for opioid use disorder treatment and behavioral health services. The bill requires Medicaid, to the extent federal financial participation is available, to cover the administration of medication-assisted treatment for opioid use disorder, and it directs the Department of Health and Human Services to seek any necessary federal waiver or State Plan amendment to secure federal funding for that coverage.
The bill also codifies and broadens Medicaid coverage for behavioral health services delivered at federally-qualified health centers. It confirms coverage for services provided by psychiatrists, psychologists, advanced practice registered nurses, marriage and family therapists, and licensed clinical social workers, and it newly adds clinical professional counselors, licensed alcohol and drug counselors, licensed clinical alcohol and drug counselors, and supervised master’s-level interns in those professions. The measure includes appropriations and authorized expenditures to implement these changes, with separate funding provisions for the opioid treatment and behavioral health components.
Impact
SB300 amends multiple provisions of NRS Chapter 422 governing Medicaid administration and coverage. It adds a statutory definition of medication-assisted treatment, requires the Director of the Department of Health and Human Services to include coverage for administration of such medication when federal matching funds are available, and updates the Department’s duties to pursue federal approval as needed. It also revises the Medicaid behavioral health services statute to place existing policy into law and expand the list of covered providers in federally-qualified health centers, while removing a duplicative definition from the incarceration-related Medicaid provision. The bill further appropriates state funds and authorizes additional non-general-fund spending to implement the new coverage requirements.
Sentiment
The bill appears to have broad bipartisan support and little visible opposition. It passed the Senate 20-0 and the Assembly 42-0, indicating unanimous support in both chambers. The overall sentiment reflected by the voting history is strongly favorable, consistent with a measure aimed at expanding access to treatment for opioid use disorder and mental health care.
Contention
No committee transcript is available, and the voting record shows no recorded opposition, so there is no documented floor-level controversy. The main policy considerations implied by the bill are fiscal cost, the need to secure federal financial participation, and the scope of provider types eligible for Medicaid reimbursement at federally-qualified health centers. Any potential concern would likely center on implementation, state matching funds, and whether the Department can obtain the necessary federal approvals, but those issues are not reflected in the available discussion or votes.